Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 16

Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study

Total article views   HTML views PDF downloads Totals
4,846 Dovepress* 4,278+ 101 4,379
PubMed Central* 568 171 739
Totals 4,846 272 5,118
*Since 27 February 2023
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar